nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP3A4—Temozolomide—malignant glioma	0.418	1	CbGbCtD
Metronidazole—Condition aggravated—Temozolomide—malignant glioma	0.0259	0.0568	CcSEcCtD
Metronidazole—Traumatic liver injury—Temozolomide—malignant glioma	0.0127	0.0278	CcSEcCtD
Metronidazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0116	0.0925	CbGpPWpGaD
Metronidazole—CYP2C8—Diclofenac Metabolic Pathway—CYP2B6—malignant glioma	0.011	0.0877	CbGpPWpGaD
Metronidazole—Disorder sight—Temozolomide—malignant glioma	0.00994	0.0218	CcSEcCtD
Metronidazole—Tongue discolouration—Temozolomide—malignant glioma	0.00979	0.0215	CcSEcCtD
Metronidazole—CYP2C8—Diclofenac Metabolic Pathway—CYP2C18—malignant glioma	0.00954	0.076	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.00945	0.0753	CbGpPWpGaD
Metronidazole—Visual acuity reduced—Temozolomide—malignant glioma	0.00795	0.0174	CcSEcCtD
Metronidazole—Encephalopathy—Carmustine—malignant glioma	0.00763	0.0167	CcSEcCtD
Metronidazole—Burning sensation—Carmustine—malignant glioma	0.00705	0.0154	CcSEcCtD
Metronidazole—Influenza-like symptoms—Temozolomide—malignant glioma	0.00662	0.0145	CcSEcCtD
Metronidazole—Menorrhagia—Temozolomide—malignant glioma	0.00639	0.014	CcSEcCtD
Metronidazole—Liver injury—Temozolomide—malignant glioma	0.00562	0.0123	CcSEcCtD
Metronidazole—Breast pain—Temozolomide—malignant glioma	0.00542	0.0119	CcSEcCtD
Metronidazole—Coordination abnormal—Carmustine—malignant glioma	0.00499	0.0109	CcSEcCtD
Metronidazole—CYP2C8—CYP2E1 reactions—CYP2B6—malignant glioma	0.0049	0.039	CbGpPWpGaD
Metronidazole—Coordination abnormal—Temozolomide—malignant glioma	0.00482	0.0106	CcSEcCtD
Metronidazole—Vaginal inflammation—Temozolomide—malignant glioma	0.00473	0.0104	CcSEcCtD
Metronidazole—Skin exfoliation—Carmustine—malignant glioma	0.00467	0.0102	CcSEcCtD
Metronidazole—Candida infection—Carmustine—malignant glioma	0.00467	0.0102	CcSEcCtD
Metronidazole—Neuropathy—Carmustine—malignant glioma	0.0046	0.0101	CcSEcCtD
Metronidazole—Influenza like illness—Temozolomide—malignant glioma	0.00459	0.0101	CcSEcCtD
Metronidazole—Candida infection—Temozolomide—malignant glioma	0.00452	0.0099	CcSEcCtD
Metronidazole—Skin exfoliation—Temozolomide—malignant glioma	0.00452	0.0099	CcSEcCtD
Metronidazole—Vaginal infection—Temozolomide—malignant glioma	0.00447	0.00979	CcSEcCtD
Metronidazole—Aplastic anaemia—Temozolomide—malignant glioma	0.00444	0.00974	CcSEcCtD
Metronidazole—Neuropathy—Temozolomide—malignant glioma	0.00444	0.00974	CcSEcCtD
Metronidazole—Neoplasm—Carmustine—malignant glioma	0.00443	0.0097	CcSEcCtD
Metronidazole—Gynaecomastia—Carmustine—malignant glioma	0.00438	0.0096	CcSEcCtD
Metronidazole—Neoplasm—Temozolomide—malignant glioma	0.00428	0.00938	CcSEcCtD
Metronidazole—Thrombophlebitis—Carmustine—malignant glioma	0.00411	0.009	CcSEcCtD
Metronidazole—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.00399	0.0318	CbGpPWpGaD
Metronidazole—Thrombophlebitis—Temozolomide—malignant glioma	0.00397	0.0087	CcSEcCtD
Metronidazole—Hepatic failure—Temozolomide—malignant glioma	0.00382	0.00838	CcSEcCtD
Metronidazole—Nasal congestion—Temozolomide—malignant glioma	0.00377	0.00827	CcSEcCtD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—POR—malignant glioma	0.00358	0.0285	CbGpPWpGaD
Metronidazole—Diplopia—Carmustine—malignant glioma	0.00355	0.00779	CcSEcCtD
Metronidazole—Diplopia—Temozolomide—malignant glioma	0.00343	0.00753	CcSEcCtD
Metronidazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00342	0.0272	CbGpPWpGaD
Metronidazole—Ataxia—Carmustine—malignant glioma	0.00334	0.00733	CcSEcCtD
Metronidazole—Liver function test abnormal—Carmustine—malignant glioma	0.00328	0.00719	CcSEcCtD
Metronidazole—Ataxia—Temozolomide—malignant glioma	0.00323	0.00708	CcSEcCtD
Metronidazole—Dry skin—Temozolomide—malignant glioma	0.00315	0.0069	CcSEcCtD
Metronidazole—Breast disorder—Temozolomide—malignant glioma	0.0031	0.0068	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00309	0.00678	CcSEcCtD
Metronidazole—CYP2C8—Xenobiotics—CYP2B6—malignant glioma	0.00304	0.0242	CbGpPWpGaD
Metronidazole—Abdominal distension—Temozolomide—malignant glioma	0.00299	0.00655	CcSEcCtD
Metronidazole—Pancytopenia—Carmustine—malignant glioma	0.00292	0.0064	CcSEcCtD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00291	0.0232	CbGpPWpGaD
Metronidazole—Neutropenia—Carmustine—malignant glioma	0.00287	0.0063	CcSEcCtD
Metronidazole—Bronchitis—Temozolomide—malignant glioma	0.00285	0.00626	CcSEcCtD
Metronidazole—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00284	0.0226	CbGpPWpGaD
Metronidazole—Pancytopenia—Temozolomide—malignant glioma	0.00282	0.00618	CcSEcCtD
Metronidazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00278	0.0222	CbGpPWpGaD
Metronidazole—Neutropenia—Temozolomide—malignant glioma	0.00278	0.00609	CcSEcCtD
Metronidazole—Dysuria—Temozolomide—malignant glioma	0.00278	0.00609	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00276	0.00605	CcSEcCtD
Metronidazole—Pollakiuria—Temozolomide—malignant glioma	0.00274	0.00601	CcSEcCtD
Metronidazole—Depression—Carmustine—malignant glioma	0.00273	0.00599	CcSEcCtD
Metronidazole—Photosensitivity reaction—Temozolomide—malignant glioma	0.00271	0.00594	CcSEcCtD
Metronidazole—Neuropathy peripheral—Carmustine—malignant glioma	0.00268	0.00589	CcSEcCtD
Metronidazole—Stomatitis—Carmustine—malignant glioma	0.00267	0.00585	CcSEcCtD
Metronidazole—Urinary tract infection—Carmustine—malignant glioma	0.00266	0.00584	CcSEcCtD
Metronidazole—Infestation NOS—Temozolomide—malignant glioma	0.00265	0.0058	CcSEcCtD
Metronidazole—Infestation—Temozolomide—malignant glioma	0.00265	0.0058	CcSEcCtD
Metronidazole—Depression—Temozolomide—malignant glioma	0.00264	0.00579	CcSEcCtD
Metronidazole—CYP2C8—Xenobiotics—CYP2C18—malignant glioma	0.00263	0.021	CbGpPWpGaD
Metronidazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00262	0.00575	CcSEcCtD
Metronidazole—Neuropathy peripheral—Temozolomide—malignant glioma	0.00259	0.00569	CcSEcCtD
Metronidazole—Stomatitis—Temozolomide—malignant glioma	0.00258	0.00566	CcSEcCtD
Metronidazole—Urinary tract infection—Temozolomide—malignant glioma	0.00257	0.00564	CcSEcCtD
Metronidazole—Hepatobiliary disease—Temozolomide—malignant glioma	0.0025	0.00549	CcSEcCtD
Metronidazole—Sinusitis—Temozolomide—malignant glioma	0.00248	0.00544	CcSEcCtD
Metronidazole—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00247	0.0197	CbGpPWpGaD
Metronidazole—Hallucination—Carmustine—malignant glioma	0.00245	0.00536	CcSEcCtD
Metronidazole—Hypoaesthesia—Carmustine—malignant glioma	0.00245	0.00536	CcSEcCtD
Metronidazole—Connective tissue disorder—Carmustine—malignant glioma	0.00242	0.0053	CcSEcCtD
Metronidazole—Hepatitis—Temozolomide—malignant glioma	0.00238	0.00521	CcSEcCtD
Metronidazole—Visual impairment—Carmustine—malignant glioma	0.00237	0.00519	CcSEcCtD
Metronidazole—Hallucination—Temozolomide—malignant glioma	0.00236	0.00518	CcSEcCtD
Metronidazole—Hypoaesthesia—Temozolomide—malignant glioma	0.00236	0.00518	CcSEcCtD
Metronidazole—Pharyngitis—Temozolomide—malignant glioma	0.00236	0.00517	CcSEcCtD
Metronidazole—Connective tissue disorder—Temozolomide—malignant glioma	0.00233	0.00512	CcSEcCtD
Metronidazole—Eye disorder—Carmustine—malignant glioma	0.0023	0.00504	CcSEcCtD
Metronidazole—Visual impairment—Temozolomide—malignant glioma	0.00229	0.00502	CcSEcCtD
Metronidazole—Flushing—Carmustine—malignant glioma	0.00228	0.005	CcSEcCtD
Metronidazole—Erythema multiforme—Temozolomide—malignant glioma	0.00225	0.00493	CcSEcCtD
Metronidazole—Eye disorder—Temozolomide—malignant glioma	0.00222	0.00487	CcSEcCtD
Metronidazole—Tinnitus—Temozolomide—malignant glioma	0.00222	0.00486	CcSEcCtD
Metronidazole—Flushing—Temozolomide—malignant glioma	0.0022	0.00483	CcSEcCtD
Metronidazole—Cardiac disorder—Temozolomide—malignant glioma	0.0022	0.00483	CcSEcCtD
Metronidazole—Angiopathy—Temozolomide—malignant glioma	0.00216	0.00473	CcSEcCtD
Metronidazole—Mental disorder—Carmustine—malignant glioma	0.00215	0.00472	CcSEcCtD
Metronidazole—Immune system disorder—Temozolomide—malignant glioma	0.00215	0.00471	CcSEcCtD
Metronidazole—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.00214	0.0171	CbGpPWpGaD
Metronidazole—Mediastinal disorder—Temozolomide—malignant glioma	0.00214	0.00469	CcSEcCtD
Metronidazole—Erythema—Carmustine—malignant glioma	0.00214	0.00469	CcSEcCtD
Metronidazole—Mental disorder—Temozolomide—malignant glioma	0.00208	0.00456	CcSEcCtD
Metronidazole—Back pain—Carmustine—malignant glioma	0.00207	0.00454	CcSEcCtD
Metronidazole—Erythema—Temozolomide—malignant glioma	0.00207	0.00453	CcSEcCtD
Metronidazole—Dysgeusia—Temozolomide—malignant glioma	0.00203	0.00444	CcSEcCtD
Metronidazole—Vision blurred—Carmustine—malignant glioma	0.00202	0.00442	CcSEcCtD
Metronidazole—Tremor—Carmustine—malignant glioma	0.002	0.0044	CcSEcCtD
Metronidazole—Back pain—Temozolomide—malignant glioma	0.002	0.00439	CcSEcCtD
Metronidazole—Vision blurred—Temozolomide—malignant glioma	0.00195	0.00427	CcSEcCtD
Metronidazole—Tremor—Temozolomide—malignant glioma	0.00194	0.00425	CcSEcCtD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00192	0.0153	CbGpPWpGaD
Metronidazole—Leukopenia—Carmustine—malignant glioma	0.00192	0.0042	CcSEcCtD
Metronidazole—Angioedema—Temozolomide—malignant glioma	0.00189	0.00414	CcSEcCtD
Metronidazole—Malaise—Temozolomide—malignant glioma	0.00186	0.00409	CcSEcCtD
Metronidazole—Vertigo—Temozolomide—malignant glioma	0.00186	0.00407	CcSEcCtD
Metronidazole—Convulsion—Carmustine—malignant glioma	0.00185	0.00407	CcSEcCtD
Metronidazole—Leukopenia—Temozolomide—malignant glioma	0.00185	0.00406	CcSEcCtD
Metronidazole—Hypertension—Carmustine—malignant glioma	0.00185	0.00405	CcSEcCtD
Metronidazole—Palpitations—Temozolomide—malignant glioma	0.00183	0.00401	CcSEcCtD
Metronidazole—Chest pain—Carmustine—malignant glioma	0.00182	0.00399	CcSEcCtD
Metronidazole—Convulsion—Temozolomide—malignant glioma	0.00179	0.00393	CcSEcCtD
Metronidazole—Hypertension—Temozolomide—malignant glioma	0.00179	0.00391	CcSEcCtD
Metronidazole—Confusional state—Carmustine—malignant glioma	0.00176	0.00386	CcSEcCtD
Metronidazole—Arthralgia—Temozolomide—malignant glioma	0.00176	0.00386	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00175	0.00383	CcSEcCtD
Metronidazole—Oedema—Carmustine—malignant glioma	0.00175	0.00383	CcSEcCtD
Metronidazole—Infection—Carmustine—malignant glioma	0.00174	0.0038	CcSEcCtD
Metronidazole—Dry mouth—Temozolomide—malignant glioma	0.00172	0.00378	CcSEcCtD
Metronidazole—Thrombocytopenia—Carmustine—malignant glioma	0.00171	0.00375	CcSEcCtD
Metronidazole—Confusional state—Temozolomide—malignant glioma	0.0017	0.00373	CcSEcCtD
Metronidazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.0017	0.0135	CbGpPWpGaD
Metronidazole—Anaphylactic shock—Temozolomide—malignant glioma	0.00169	0.0037	CcSEcCtD
Metronidazole—Oedema—Temozolomide—malignant glioma	0.00169	0.0037	CcSEcCtD
Metronidazole—Infection—Temozolomide—malignant glioma	0.00168	0.00368	CcSEcCtD
Metronidazole—Anorexia—Carmustine—malignant glioma	0.00166	0.00365	CcSEcCtD
Metronidazole—Nervous system disorder—Temozolomide—malignant glioma	0.00166	0.00363	CcSEcCtD
Metronidazole—Thrombocytopenia—Temozolomide—malignant glioma	0.00165	0.00362	CcSEcCtD
Metronidazole—Skin disorder—Temozolomide—malignant glioma	0.00164	0.00359	CcSEcCtD
Metronidazole—Hyperhidrosis—Temozolomide—malignant glioma	0.00163	0.00358	CcSEcCtD
Metronidazole—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00163	0.013	CbGpPWpGaD
Metronidazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00162	0.0129	CbGpPWpGaD
Metronidazole—Anorexia—Temozolomide—malignant glioma	0.00161	0.00353	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00159	0.00349	CcSEcCtD
Metronidazole—Insomnia—Carmustine—malignant glioma	0.00158	0.00346	CcSEcCtD
Metronidazole—Paraesthesia—Carmustine—malignant glioma	0.00157	0.00344	CcSEcCtD
Metronidazole—Somnolence—Carmustine—malignant glioma	0.00155	0.0034	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00154	0.00337	CcSEcCtD
Metronidazole—Insomnia—Temozolomide—malignant glioma	0.00153	0.00335	CcSEcCtD
Metronidazole—Decreased appetite—Carmustine—malignant glioma	0.00152	0.00333	CcSEcCtD
Metronidazole—Paraesthesia—Temozolomide—malignant glioma	0.00152	0.00332	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Carmustine—malignant glioma	0.00151	0.00331	CcSEcCtD
Metronidazole—Somnolence—Temozolomide—malignant glioma	0.0015	0.00329	CcSEcCtD
Metronidazole—Constipation—Carmustine—malignant glioma	0.00149	0.00327	CcSEcCtD
Metronidazole—Pain—Carmustine—malignant glioma	0.00149	0.00327	CcSEcCtD
Metronidazole—Dyspepsia—Temozolomide—malignant glioma	0.00149	0.00326	CcSEcCtD
Metronidazole—Decreased appetite—Temozolomide—malignant glioma	0.00147	0.00322	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00146	0.0032	CcSEcCtD
Metronidazole—Fatigue—Temozolomide—malignant glioma	0.00146	0.00319	CcSEcCtD
Metronidazole—Pain—Temozolomide—malignant glioma	0.00144	0.00316	CcSEcCtD
Metronidazole—Constipation—Temozolomide—malignant glioma	0.00144	0.00316	CcSEcCtD
Metronidazole—Feeling abnormal—Carmustine—malignant glioma	0.00144	0.00316	CcSEcCtD
Metronidazole—Gastrointestinal pain—Carmustine—malignant glioma	0.00143	0.00313	CcSEcCtD
Metronidazole—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00141	0.0113	CbGpPWpGaD
Metronidazole—Feeling abnormal—Temozolomide—malignant glioma	0.00139	0.00305	CcSEcCtD
Metronidazole—Abdominal pain—Carmustine—malignant glioma	0.00138	0.00303	CcSEcCtD
Metronidazole—Body temperature increased—Carmustine—malignant glioma	0.00138	0.00303	CcSEcCtD
Metronidazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.00138	0.00303	CcSEcCtD
Metronidazole—Urticaria—Temozolomide—malignant glioma	0.00134	0.00294	CcSEcCtD
Metronidazole—Body temperature increased—Temozolomide—malignant glioma	0.00133	0.00293	CcSEcCtD
Metronidazole—Abdominal pain—Temozolomide—malignant glioma	0.00133	0.00293	CcSEcCtD
Metronidazole—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00132	0.0106	CbGpPWpGaD
Metronidazole—Hypersensitivity—Carmustine—malignant glioma	0.00129	0.00282	CcSEcCtD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00126	0.01	CbGpPWpGaD
Metronidazole—Asthenia—Carmustine—malignant glioma	0.00125	0.00275	CcSEcCtD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00124	0.00992	CbGpPWpGaD
Metronidazole—Hypersensitivity—Temozolomide—malignant glioma	0.00124	0.00273	CcSEcCtD
Metronidazole—Asthenia—Temozolomide—malignant glioma	0.00121	0.00266	CcSEcCtD
Metronidazole—Diarrhoea—Carmustine—malignant glioma	0.0012	0.00262	CcSEcCtD
Metronidazole—Pruritus—Temozolomide—malignant glioma	0.00119	0.00262	CcSEcCtD
Metronidazole—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00118	0.00936	CbGpPWpGaD
Metronidazole—Dizziness—Carmustine—malignant glioma	0.00115	0.00253	CcSEcCtD
Metronidazole—Diarrhoea—Temozolomide—malignant glioma	0.00115	0.00253	CcSEcCtD
Metronidazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00112	0.00892	CbGpPWpGaD
Metronidazole—Dizziness—Temozolomide—malignant glioma	0.00112	0.00245	CcSEcCtD
Metronidazole—Vomiting—Carmustine—malignant glioma	0.00111	0.00243	CcSEcCtD
Metronidazole—Rash—Carmustine—malignant glioma	0.0011	0.00241	CcSEcCtD
Metronidazole—Dermatitis—Carmustine—malignant glioma	0.0011	0.00241	CcSEcCtD
Metronidazole—Headache—Carmustine—malignant glioma	0.00109	0.0024	CcSEcCtD
Metronidazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00109	0.00871	CbGpPWpGaD
Metronidazole—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00108	0.0086	CbGpPWpGaD
Metronidazole—Vomiting—Temozolomide—malignant glioma	0.00107	0.00235	CcSEcCtD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00107	0.0085	CbGpPWpGaD
Metronidazole—Rash—Temozolomide—malignant glioma	0.00106	0.00233	CcSEcCtD
Metronidazole—Dermatitis—Temozolomide—malignant glioma	0.00106	0.00233	CcSEcCtD
Metronidazole—Headache—Temozolomide—malignant glioma	0.00106	0.00232	CcSEcCtD
Metronidazole—Nausea—Carmustine—malignant glioma	0.00104	0.00227	CcSEcCtD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00103	0.00818	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00102	0.00815	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00101	0.00807	CbGpPWpGaD
Metronidazole—Nausea—Temozolomide—malignant glioma	0.001	0.0022	CcSEcCtD
Metronidazole—CYP2C8—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000959	0.00764	CbGpPWpGaD
Metronidazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00089	0.00709	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000887	0.00706	CbGpPWpGaD
Metronidazole—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000878	0.007	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000832	0.00663	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00078	0.00622	CbGpPWpGaD
Metronidazole—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000726	0.00578	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000722	0.00575	CbGpPWpGaD
Metronidazole—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000719	0.00573	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000677	0.00539	CbGpPWpGaD
Metronidazole—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000672	0.00535	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000668	0.00532	CbGpPWpGaD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000587	0.00468	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000579	0.00461	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000549	0.00437	CbGpPWpGaD
Metronidazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000547	0.00436	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.000543	0.00433	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.000536	0.00427	CbGpPWpGaD
Metronidazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000518	0.00412	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000476	0.00379	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.000471	0.00375	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.000464	0.0037	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000442	0.00352	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000436	0.00347	CbGpPWpGaD
Metronidazole—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000396	0.00316	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000383	0.00305	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.000381	0.00303	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000378	0.00301	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000367	0.00293	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000361	0.00287	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.000357	0.00284	CbGpPWpGaD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000341	0.00272	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.00031	0.00247	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000299	0.00238	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000292	0.00232	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.00029	0.00231	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000288	0.00229	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000267	0.00213	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000264	0.0021	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.00026	0.00207	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000253	0.00201	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000249	0.00199	CbGpPWpGaD
Metronidazole—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000219	0.00174	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000217	0.00173	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000215	0.00171	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000212	0.00169	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000204	0.00163	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000192	0.00153	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000191	0.00152	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000185	0.00147	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000155	0.00124	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—COX8A—malignant glioma	0.000153	0.00122	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00015	0.0012	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000143	0.00114	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000142	0.00113	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00014	0.00111	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000137	0.00109	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ASMT—malignant glioma	0.00013	0.00104	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000127	0.00102	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—COX8A—malignant glioma	0.000125	0.000994	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—BCAN—malignant glioma	0.000123	0.000976	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000112	0.000889	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ASMT—malignant glioma	0.000106	0.000845	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000104	0.000826	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—BCAN—malignant glioma	9.97e-05	0.000795	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—IDH2—malignant glioma	9.88e-05	0.000787	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.32e-05	0.000742	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2B6—malignant glioma	9.29e-05	0.00074	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—IDH1—malignant glioma	8.5e-05	0.000677	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—COX8A—malignant glioma	8.23e-05	0.000656	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SPHK1—malignant glioma	8.22e-05	0.000655	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP2C18—malignant glioma	8.05e-05	0.000642	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—IDH2—malignant glioma	8.04e-05	0.000641	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.59e-05	0.000605	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.58e-05	0.000604	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	7.56e-05	0.000602	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ASMT—malignant glioma	7e-05	0.000557	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.92e-05	0.000551	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—IDH1—malignant glioma	6.91e-05	0.000551	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SPHK1—malignant glioma	6.69e-05	0.000533	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.68e-05	0.000532	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—BCAN—malignant glioma	6.58e-05	0.000524	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	6.55e-05	0.000522	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTT1—malignant glioma	6.51e-05	0.000519	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.18e-05	0.000492	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTGS1—malignant glioma	6.1e-05	0.000486	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.08e-05	0.000484	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—BCHE—malignant glioma	5.67e-05	0.000452	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.63e-05	0.000449	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SLC5A5—malignant glioma	5.6e-05	0.000447	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.43e-05	0.000433	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—IDH2—malignant glioma	5.3e-05	0.000422	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTT1—malignant glioma	5.3e-05	0.000422	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.3e-05	0.000422	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.25e-05	0.000418	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.99e-05	0.000397	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTGS1—malignant glioma	4.97e-05	0.000396	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.95e-05	0.000394	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—BCHE—malignant glioma	4.62e-05	0.000368	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.58e-05	0.000365	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.56e-05	0.000363	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—IDH1—malignant glioma	4.56e-05	0.000363	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTP1—malignant glioma	4.51e-05	0.00036	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SPHK1—malignant glioma	4.41e-05	0.000352	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CAT—malignant glioma	4.39e-05	0.00035	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.32e-05	0.000344	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.31e-05	0.000344	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.27e-05	0.000341	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NCOR1—malignant glioma	4.15e-05	0.000331	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.73e-05	0.000297	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTP1—malignant glioma	3.67e-05	0.000293	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CAT—malignant glioma	3.58e-05	0.000285	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTT1—malignant glioma	3.5e-05	0.000279	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CAV1—malignant glioma	3.38e-05	0.000269	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NCOR1—malignant glioma	3.38e-05	0.000269	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTGS1—malignant glioma	3.28e-05	0.000261	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.23e-05	0.000257	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CG—malignant glioma	3.08e-05	0.000245	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—BCHE—malignant glioma	3.05e-05	0.000243	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.01e-05	0.00024	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPARG—malignant glioma	2.97e-05	0.000237	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CAV1—malignant glioma	2.75e-05	0.000219	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CD—malignant glioma	2.71e-05	0.000216	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.63e-05	0.00021	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.51e-05	0.0002	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTP1—malignant glioma	2.42e-05	0.000193	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPARG—malignant glioma	2.42e-05	0.000193	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.36e-05	0.000188	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CAT—malignant glioma	2.36e-05	0.000188	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTGS2—malignant glioma	2.34e-05	0.000186	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NCOR1—malignant glioma	2.23e-05	0.000177	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.2e-05	0.000176	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTEN—malignant glioma	2.04e-05	0.000163	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.92e-05	0.000153	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTGS2—malignant glioma	1.9e-05	0.000152	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CAV1—malignant glioma	1.82e-05	0.000145	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTEN—malignant glioma	1.66e-05	0.000132	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.65e-05	0.000132	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPARG—malignant glioma	1.6e-05	0.000127	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.45e-05	0.000116	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.44e-05	0.000115	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.27e-05	0.000101	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTGS2—malignant glioma	1.26e-05	0.0001	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKT1—malignant glioma	1.18e-05	9.37e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.17e-05	9.33e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTEN—malignant glioma	1.09e-05	8.72e-05	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKT1—malignant glioma	9.57e-06	7.62e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.72e-06	6.15e-05	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKT1—malignant glioma	6.31e-06	5.03e-05	CbGpPWpGaD
